ea0035p598 | Endocrine tumours and neoplasia | ECE2014
Diakatou Evanthia
, Tsolakis Apostolos
, Alexandraki Krystallenia
, Chatzellis Eleftherios
, Leonti Anastasia
, Kontogeorgos Georgios
, Kaltsas Gregory
Background: The expression and/or co-expression of somatostatin (sstr15) and dopamine (DR) receptors in neuroendocrine tumors (NETS) is of clinical interest as their expression implies that NETS could be treated with combined targeted therapy. In addition, the expression of sstrs permits tumour visualization with radiolabelled sst analogs (111In-DTPA-OctreoScan).Methods: We analyzed preoperative Octreoscans findings (also graded for the ...